1. Home
  2. VERA vs CUBI Comparison

VERA vs CUBI Comparison

Compare VERA & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • CUBI
  • Stock Information
  • Founded
  • VERA 2016
  • CUBI 1994
  • Country
  • VERA United States
  • CUBI United States
  • Employees
  • VERA N/A
  • CUBI N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • CUBI Major Banks
  • Sector
  • VERA Health Care
  • CUBI Finance
  • Exchange
  • VERA Nasdaq
  • CUBI Nasdaq
  • Market Cap
  • VERA 2.0B
  • CUBI 1.7B
  • IPO Year
  • VERA 2021
  • CUBI 2012
  • Fundamental
  • Price
  • VERA $24.00
  • CUBI $65.95
  • Analyst Decision
  • VERA Buy
  • CUBI Buy
  • Analyst Count
  • VERA 8
  • CUBI 10
  • Target Price
  • VERA $64.63
  • CUBI $65.67
  • AVG Volume (30 Days)
  • VERA 2.3M
  • CUBI 323.6K
  • Earning Date
  • VERA 08-07-2025
  • CUBI 07-24-2025
  • Dividend Yield
  • VERA N/A
  • CUBI N/A
  • EPS Growth
  • VERA N/A
  • CUBI N/A
  • EPS
  • VERA N/A
  • CUBI 3.98
  • Revenue
  • VERA N/A
  • CUBI $591,500,000.00
  • Revenue This Year
  • VERA N/A
  • CUBI $12.34
  • Revenue Next Year
  • VERA N/A
  • CUBI $10.08
  • P/E Ratio
  • VERA N/A
  • CUBI $16.56
  • Revenue Growth
  • VERA N/A
  • CUBI N/A
  • 52 Week Low
  • VERA $18.53
  • CUBI $40.75
  • 52 Week High
  • VERA $51.61
  • CUBI $68.49
  • Technical
  • Relative Strength Index (RSI)
  • VERA 54.33
  • CUBI 83.74
  • Support Level
  • VERA $22.76
  • CUBI $58.52
  • Resistance Level
  • VERA $23.97
  • CUBI $51.55
  • Average True Range (ATR)
  • VERA 1.21
  • CUBI 1.84
  • MACD
  • VERA 0.15
  • CUBI 1.29
  • Stochastic Oscillator
  • VERA 73.63
  • CUBI 92.76

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.

Share on Social Networks: